Nov 08, 2019 / 01:00PM GMT
Operator
Good morning, and welcome to the Recro Third Quarter 2019 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded at the company's request.
I would now like to turn the call over to Claudia Styslinger, Investor Relations. You may begin.
Claudia Styslinger - Argot Partners, LLC - IR Associate
Good morning, and thank you for joining us on today's conference call to discuss Recro's third quarter 2019 financial results. This is Claudia Styslinger, and I am joined today by Gerri Henwood, President and Chief Executive Officer; and Ryan Lake, Chief Financial Officer. Following prepared remarks today by Gerri and Ryan, we will open the call for questions.
Earlier this morning, we issued a press release detailing our financial and operating results for the 3 and 9 months ended September 30, 2019. The press release is available on the News & Investors page of our website at recropharma.com.
Before we begin our formal comments, I'll remind you that various remarks we make today constitute
Q3 2019 Recro Pharma Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot